Getting naloxone into the hands of people who might witness an overdose is a matter of life and death. A new report shows a promising sign: the number of naloxone prescriptions filled at U.S. retail pharmacies more than doubled from 2017 to 2018. This suggests that efforts to make this life-saving medication more available are gaining traction.
The report looked at national dispensing trends from 2012 through 2018, finding a substantial increase overall, with the sharpest jump happening in that final year. It didn't track who specifically got the prescriptions or how many individual patients were involved, but the rise in dispensed prescriptions points to broader access.
It's important to understand what this report can and cannot tell us. This is an observational look at pharmacy data, not a controlled study. It shows that more naloxone is moving through pharmacies, but it doesn't prove that this increase directly caused fewer overdose deaths or that the medication is reaching every community equally. The report doesn't include information on safety, but naloxone is widely recognized as safe and effective for emergency use.
While the doubling of prescriptions is an encouraging marker, the real-world impact depends on whether the people most likely to be present during an overdose—friends, family, and community members—actually have it on hand when crisis strikes. This data is a snapshot of progress in one part of the system.
